Want to see GANX full AI Analyst Report?
Gain Therapeutics (GANX) Ownership - Who Owns Gain Therapeutics?
Gain Therapeutics (GANX) Ownership Overview
- 2.23% Insiders
- 1.93% Mutual Funds
- 0.13% Other Institutional Investors
- 1.52% ETFs
- 94.19% Public Companies and Individual Investors
The ownership structure of Gain Therapeutics (GANX) stock is a mix of institutional, retail, and individual investors. Approximately 3.57% of the company’s stock is owned by Institutional Investors, 2.23% is owned by Insiders, and 94.19% is owned by Public Companies and Individual Investors.
The ownership structure of Gain Therapeutics (GANX) stock is a mix of institutional, retail, and individual investors. Approximately 2.06% of the company’s stock is owned by Institutional Investors, 2.23% is owned by Insiders, and 1.52% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Khalid Islam | 930,784 | Insider | 2.13% | 1,051,786 |
| Vanguard | 480,269 | Institution | 1.10% | 542,704 |
| Vanguard Index Funds | 430,902 | Institution | 0.99% | 486,919 |
| Fidelity Concord Street Trust | 378,538 | Institution | 0.87% | 427,748 |
| Ishares | 130,887 | Institution | 0.30% | 147,902 |
| Bridgeway | 51,874 | Institution | 0.12% | 58,618 |
| Bridgeway Funds, Inc. | 30,004 | Institution | 0.07% | 33,905 |
| Jeffrey Scott Riley | 30,000 | Insider | 0.07% | 33,900 |
| Gene Mack | 14,400 | Insider | 0.03% | 16,272 |
| Victory Portfolios Iii | 1,011 | Institution | <0.01% | 1,142 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 430,902 | Institution | 0.99% | 486,919 |
| Fidelity Concord Street Trust | 378,538 | Institution | 0.87% | 427,748 |
| Bridgeway Funds, Inc. | 30,004 | Institution | 0.07% | 33,905 |
| Victory Portfolios Iii | 1,011 | Institution | <0.01% | 1,142 |
| John Hancock Variable Insurance Trust | 966 | Institution | <0.01% | 1,092 |
Top ETF Holders
FAQ
Who Owns Gain Therapeutics (GANX)?
According to the latest TipRanks data, approximately 0.13% of the company's stock is held by institutional investors, 2.23% is held by insiders, and 94.19% is held by retail investors.
What percentage of Gain Therapeutics (GANX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.13% of Gain Therapeutics (GANX) stock is held by institutional investors.
What percentage of Gain Therapeutics (GANX) stock is held by retail investors?
According to the latest TipRanks data, approximately 94.19% of Gain Therapeutics (GANX) stock is held by retail investors.
Who owns the most shares of Gain Therapeutics (GANX)?
Khalid Islam owns the most shares of Gain Therapeutics (GANX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.